UBS AM’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-7,236
| Closed | -$268K | – | 2901 |
|
|
2021
Q3 | $268K | Hold |
7,236
| – | – | ﹤0.01% | 2642 |
|
|
2021
Q2 | $431K | Buy |
7,236
+2,512
| +53% | +$149K | ﹤0.01% | 2580 |
|
|
2021
Q1 | $317K | Buy |
4,724
+2,353
| +99% | +$158K | ﹤0.01% | 2477 |
|
|
2020
Q4 | $143K | Sell |
2,371
-1,290
| -35% | -$78K | ﹤0.01% | 2526 |
|
|
2020
Q3 | $289K | Sell |
3,661
-980
| -21% | -$77.4K | ﹤0.01% | 2313 |
|
|
2020
Q2 | $290K | Buy |
4,641
+1,010
| +28% | +$63.1K | ﹤0.01% | 2292 |
|
|
2020
Q1 | $192K | Sell |
3,631
-487
| -12% | -$25.8K | ﹤0.01% | 2289 |
|
|
2019
Q4 | $498K | Buy |
4,118
+18
| +0.4% | +$2.18K | ﹤0.01% | 2237 |
|
|
2019
Q3 | $744K | Buy |
4,100
+1,221
| +42% | +$222K | ﹤0.01% | 2095 |
|
|
2019
Q2 | $374K | Buy |
2,879
+471
| +20% | +$61.2K | ﹤0.01% | 2331 |
|
|
2019
Q1 | $586K | Buy |
2,408
+199
| +9% | +$48.5K | ﹤0.01% | 2047 |
|
|
2018
Q4 | $421K | Sell |
2,209
-56
| -2% | -$10.7K | ﹤0.01% | 2064 |
|
|
2018
Q3 | $743K | Buy |
2,265
+33
| +1% | +$10.8K | ﹤0.01% | 1917 |
|
|
2018
Q2 | $697K | Buy |
2,232
+11
| +0.5% | +$3.43K | ﹤0.01% | 1951 |
|
|
2018
Q1 | $541K | Buy |
2,221
+256
| +13% | +$62.3K | ﹤0.01% | 2006 |
|
|
2017
Q4 | $594K | Buy |
1,965
+86
| +5% | +$26K | ﹤0.01% | 1916 |
|
|
2017
Q3 | $497K | Buy |
1,879
+199
| +12% | +$52.6K | ﹤0.01% | 1951 |
|
|
2017
Q2 | $443K | Sell |
1,680
-24
| -1% | -$6.32K | ﹤0.01% | 1917 |
|
|
2017
Q1 | $614K | Buy |
1,704
+215
| +14% | +$77.4K | ﹤0.01% | 1797 |
|
|
2016
Q4 | $430K | Sell |
1,489
-706
| -32% | -$204K | ﹤0.01% | 1847 |
|
|
2016
Q3 | $748K | Buy |
2,195
+76
| +4% | +$25.9K | ﹤0.01% | 1796 |
|
|
2016
Q2 | $902K | Buy |
2,119
+345
| +19% | +$147K | ﹤0.01% | 1703 |
|
|
2016
Q1 | $567K | Sell |
1,774
-201
| -10% | -$64.2K | ﹤0.01% | 1862 |
|
|
2015
Q4 | $1.02M | Buy |
1,975
+541
| +38% | +$280K | ﹤0.01% | 1738 |
|
|
2015
Q3 | $420K | Buy |
1,434
+480
| +50% | +$141K | ﹤0.01% | 2106 |
|
|
2015
Q2 | $375K | Buy |
+954
| New | +$375K | ﹤0.01% | 2227 |
|